Wednesday, August 6, 2025

Measles

Measles: The Deadliest Preventable Diseases

~Introduction

Measles is a highly contagious viral disease that has plagued humanity for centuries. Despite the availability of a safe and effective vaccine, measles continues to cause significant morbidity and mortality, especially among children in developing countries. The World Health Organization (WHO) has labeled measles as one of the leading causes of vaccine-preventable deaths worldwide.

This article explores the historical background, virology, symptoms, transmission, complications, diagnosis, treatment, prevention, and global impact of measles. It also discusses ongoing efforts and challenges in achieving measles elimination.

~Historical Background

Measles has been a known disease for over 1000 years. The Persian physician Rhazes (Al-Razi) provided the first clinical description in the 9th century.

Key historical milestones:

1757: Francis Home demonstrated that measles is caused by an infectious agent.
1954: The measles virus was isolated by John Enders and Thomas Peebles.
1963: The first measles vaccine was licensed.
1971: Introduction of the MMR (measles, mumps, rubella) vaccine.
2000: Measles declared eliminated in the United States due to vaccination success (though later resurged).

Despite progress, measles remains a major health concern, particularly in regions with low vaccination coverage.

~What is Measles?

Measles is a highly contagious viral illness caused by the measles virus, a member of the Paramyxoviridae family, Morbillivirus genus. It primarily affects children but can occur at any age in unvaccinated individuals.

~Virology

RNA virus: Single-stranded, enveloped
Infects the respiratory epithelium, then spreads via the bloodstream
Has only one serotype (meaning immunity from infection or vaccination is lifelong)
No animal reservoir, making elimination possible through vaccination

~Transmission

Measles is spread via:

Respiratory droplets
Airborne particles (virus can live in air or on surfaces for up to 2 hours)

Contagious Period:

Starts 4 days before and ends 4 days after the rash appears

Basic Reproduction Number (R0):

One of the highest among infectious diseases: R0 = 12 to 18
- This means one person can infect 12–18 others in a susceptible population

~Risk Factors

Lack of vaccination
Malnutrition, especially vitamin A deficiency
Immunosuppression (HIV, cancer)
Infants and young children
Living in crowded conditions

~Signs and Symptoms

The symptoms appear 10 to 14 days after exposure. Measles has three clinical stages:

1. Prodromal Stage (Initial Symptoms)

High fever (often >104°F or 40°C)
Cough
Runny nose (coryza)
Red, watery eyes (conjunctivitis)
Malaise
Anorexia

2. Koplik’s Spots (Pathognomonic Sign)

Tiny white/blue spots inside the mouth, on the inner cheeks (buccal mucosa)
Appear 1–2 days before the skin rash

3. Exanthem (Skin Rash)

Begins on the face and spreads to the trunk and limbs
Maculopapular, red, and confluent
Fades in the same order of appearance
Accompanied by high fever

~Complications of Measles

Measles is often viewed as a harmless childhood illness, but it can cause serious complications, especially in children under 5 and adults over 20.

Common Complications:

Ear infections – May lead to hearing loss
Pneumonia – Most common cause of death
Diarrhea and dehydration

Severe Complications:

Encephalitis (brain inflammation)
Blindness
Seizures
Acute respiratory distress syndrome (ARDS)
Subacute Sclerosing Panencephalitis (SSPE) – A rare, fatal brain disorder occurring years after infection

Death Rate:

Worldwide, about 1 in every 1000 children with measles dies from complications.
Higher in malnourished children and regions with poor healthcare access.

~Diagnosis

Clinical Diagnosis:

History of fever, cough, coryza, conjunctivitis, and rash
Presence of Koplik’s spots is highly suggestive

Laboratory Diagnosis:

Serology: Detection of measles-specific IgM antibodies
RT-PCR: Detects measles RNA from throat or nasal swabs
Viral culture: Rarely done
Leukopenia (low white blood cell count) may be seen

~Treatment

There is no specific antiviral treatment for measles. Management is supportive, aimed at relieving symptoms and preventing complications.

Supportive Care:

Hydration
Antipyretics (e.g., paracetamol for fever)
Nutritional support
Treat secondary infections (e.g., antibiotics for pneumonia)

Vitamin A Supplementation:

Reduces severity and mortality
WHO recommends two doses for all children diagnosed with measles

~Prevention

1. Measles Vaccination

The cornerstone of prevention.

Live attenuated vaccine
Given as part of MMR (Measles, Mumps, Rubella) or MR (Measles-Rubella) vaccines

Schedule:

First dose: 9–12 months of age
Second dose: 15–18 months or before school entry

2. Herd Immunity

To prevent outbreaks, 95% of the population must be immune (via vaccination or previous infection).

3. Post-Exposure Prophylaxis (PEP):

MMR vaccine within 72 hours of exposure
Immune globulin (IG) within 6 days for high-risk individuals (infants, pregnant women, immunocompromised)

4. Isolation:

Infected individuals should be isolated for at least 4 days after rash onset

~Global Impact of Measles

Despite being preventable, measles remains a leading cause of death among young children globally.

Key Statistics (WHO):

In 2022, over 140,000 measles-related deaths were reported
90% occurred in low-income countries
Over 95% of measles deaths occur in countries with weak health infrastructure

Countries Most Affected:

Democratic Republic of the Congo
Nigeria
Pakistan
India
Ethiopia

~Measles in India

India contributes a significant share of the global measles burden.

Challenges:

Population density
Migration
Vaccine hesitancy
Health infrastructure gaps in rural areas

Initiatives:

Universal Immunization Programme (UIP)
Measles-Rubella (MR) vaccination campaign launched in 2017 to cover children aged 9 months to 15 years
WHO and UNICEF support in routine immunization and surveillance

~Outbreaks and Resurgence

Recent years have witnessed resurgences of measles, even in countries that had eliminated it.

Reasons:

Vaccine hesitancy and misinformation
Decrease in vaccination due to COVID-19 pandemic
Anti-vaccination movements
Inadequate healthcare access in conflict zones

Consequences of Outbreaks:

Overwhelms health systems
Economic loss
School closures
Strain on public trust in vaccination programs

~Vaccination Myths and Misinformation

One major challenge in measles prevention is vaccine hesitancy, driven by misinformation.

Common Myths Debunked:

"Vaccines cause autism" – This claim was based on a fraudulent study, now completely debunked.
"Natural infection is better than vaccination" – Measles infection can cause life-threatening complications.
"Measles is a mild illness" – It is among the most deadly diseases for unvaccinated children.

Combating Misinformation:

Public health campaigns
Transparent communication from governments
Involving community leaders and influencers
Promoting evidence-based information

~The Path to Measles Elimination

Measles Elimination Goals:

WHO aims to eliminate measles in five out of six WHO regions
Elimination is defined as zero endemic measles cases in a region for over 12 months

Strategies:

High routine immunization coverage
Supplementary immunization activities (SIAs)
Strong surveillance systems
Rapid outbreak response

~The Role of Technology and Innovation

Modern technology plays a vital role in measles control:

GIS mapping to track vaccination coverage
Mobile health apps for reporting and surveillance
Digital immunization records
AI tools to predict outbreaks

~Case Study: The United States

The U.S. declared measles eliminated in 2000, but outbreaks have reoccurred due to unvaccinated populations.

2019 Outbreak:

Over 1,200 cases reported
Mostly among unvaccinated individuals in specific communities
Sparked public debate over vaccine mandates

~Case Study: COVID-19’s Impact on Measles

The COVID-19 pandemic disrupted routine immunization programs:

Over 40 million children missed a measles vaccine dose in 2021
Delayed mass campaigns and school closures reduced vaccine reach
Led to a surge in measles outbreaks in 2022–2023

~Future Directions

To eradicate measles globally, the world needs:

Political will and funding
Robust health systems
Equitable vaccine access
Community engagement
Global collaboration

~Conclusion

Measles is a deadly but entirely preventable disease. With a highly effective vaccine, eradication is possible. However, misinformation, vaccine hesitancy, and healthcare disparities continue to fuel outbreaks. Governments, health workers, NGOs, and communities must work together to educate, vaccinate, and eliminate measles once and for all.

Eliminating measles is not just a public health goal—it’s a moral imperative.

~Key Takeaways

Measles is one of the most contagious human diseases.
Caused by a virus and spread through airborne droplets.
Symptoms include fever, cough, Koplik's spots, and rash.
Serious complications include pneumonia, encephalitis, and death.
Vaccine is highly effective; two doses provide lifelong immunity.
WHO aims to eliminate measles globally through mass immunization.
Outbreaks are driven by misinformation, low coverage, and weak health systems.
Collective action is required to make measles history.